{"database": "press", "table": "releases", "rows": [["https://www.grassley.senate.gov/news/news-releases/cms-justice-dept-mylan-stonewall-only-delays-accountability-americans-deserve", "CMS, Justice Dept., Mylan Stonewall Only Delays Accountability Americans Deserve", "2016-11-23", "2016", "2016-11", "Republican", "House", "IA", "Charles Grassley", "G000386", "www.grassley.senate.gov", null, null, "legacy", "Judiciary Committee Postpones EpiPen Hearing; Considers Tools to Compel Participation\u00a0WASHINGTON \u2013 The Senate Judiciary Committee is postponing a hearing on the potential settlement agreement between EpiPen maker Mylan and the Obama Administration as it considers other avenues to ensure government and company witnesses participate. \u00a0Representatives from the Justice Department, the Centers for Medicare and Medicaid Services and Mylan have refused to attend the hearing to examine a reported settlement agreement as well as Mylan\u2019s classification procedures and agencies\u2019 authorities to prevent and respond to drug companies that misrepresent their products to the government.\u201cI\u2019m disappointed in the decisions by Mylan, CMS and the Justice Department to delay accountability that American patients and taxpayers deserve. But their decision to duck appropriate scrutiny will not stop this committee\u2019s pursuit for answers. Congress has a constitutional duty to conduct oversight and hearings are an important part of that process. Unfortunately, because of the unconventional refusal by these three entities to attend, we must now consider compelling their participation.\u00a0\u201cIt appears that Mylan\u2019s misclassification of the EpiPen has forced taxpayers and states to foot an unnecessarily higher bill throughout the duration of the Obama Administration, despite notifications to CMS. \u00a0Both Mylan and the Obama Administration need to answer to these issues. Americans deserve accountability, especially on decisions that impact their health and economic wellbeing. \u00a0This committee will not stop until our questions are answered and any appropriate actions are taken,\u201d Grassley said.The Justice Department, CMS and Mylan cited pending matters and investigations as their reasoning for not attending the hearing. However, Mylan announced a settlement with the Justice Department on Oct. 7, mentioning specific terms in the alleged settlement and drawing the issue into the public eye. \u00a0The Justice Department has said there is no \u201cexecuted settlement.\u201d \u00a0The hearing would also focus on agency authorities to prevent and address drug misclassifications and whether such misclassifications violate the False Claims Act. \u00a0These matters could be discussed without addressing specifics of any pending matter.-30-", 1, "2026-03-30T12:14:52Z", "2026-03-30T12:14:52Z"]], "columns": ["url", "title", "date", "year", "month", "party", "chamber", "state", "member_name", "bioguide_id", "domain", "scraper", "source", "date_source", "text", "has_text", "collected_at", "updated_at"], "primary_keys": ["url"], "primary_key_values": ["https://www.grassley.senate.gov/news/news-releases/cms-justice-dept-mylan-stonewall-only-delays-accountability-americans-deserve"], "units": {}, "query_ms": 1.5920521691441536, "source": "dwillis/congress-press", "source_url": "https://github.com/dwillis/congress-press", "license": "MIT", "license_url": "https://github.com/dwillis/congress-press/blob/main/LICENSE"}